1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Associations of selected features with occurrence of GLOS
Features Univariable Analysis Multivariable Analysis OR (95% CI) P Value OR (95% CI) P Value Age (yr) 1.051 (1.020–1.083) .001 1.025 (0.988–1.064) .189 Sex 0.947 (0.427–2.096) .892 0.679 (0.290–1.586) .679 Creatinine (µmol/L) 1.026 (1.010–1.041) .001 eGFR (mL/min/1.73 m2) 0.961 (0.943–0.979) <.001 0.970 (0.049–0.992) .008 Time interval between GBCA injection and index brain MR imaging (hr) 0.986 (0.976–0.996) .005 0.987 (0.977–0.997) .012 Frequency of GBCA injections 1.268 (0.338–4.753) .725 GBCA doses (mL) 1.025 (0.968–1.085) .572 GBCA types 1.190 (0.582–2.433) .633 Prior cataract surgery 3.744 (1.477–9.490) .005 1.284 (0.431–3.823) .653